Free Tool · No Email · Instant

GLP-1 cost calculator :
Imbue vs. anyone

See exactly how much you'd pay each month and each year for brand-name FDA-approved GLP-1 medication on Imbue Health vs 11 other major U.S. telehealth providers. Pick your medication, pick your alternative, see the gap.

Last clinically reviewed: May 14, 2026 by the Imbue Health Medical Team

Configure your comparison

Your savings on Imbue

Per month

$120

vs Hims

Per year

$1,440saved

Imbue Health — membership$29/mo
Hims & Hersmembership$149/mo

Hims is quoted membership-only (medication priced separately). Comparison is membership vs membership.

Save $1,440/yr — Get Started

Estimates only. Competitor pricing reflects publicly listed rates as of 2026. Actual cost may vary based on dose, insurance coverage, and manufacturer programs. See full comparison for the underlying numbers.

How the calculator works

Imbue total = $29/month membership + the chosen medication's manufacturer cash-pay rate via NovoCare or LillyDirect. Pricing is fixed and published. We do not estimate — these are the exact rates a patient pays.

Competitor total = the midpoint of each provider's estimated brand-name-path monthly cost range. Each competitor publishes a different combination of membership fees, medication markups, and bundled pricing — the ranges in the underlying data reflect this. For providers that only sell compounded medication, the range reflects their compounded bundled price (not a brand-name equivalent).

Annual savings = (competitor monthly cost × 12) − (Imbue monthly cost × 12). We clamp to zero — if a competitor happens to be cheaper for your specific combination, we don't show a negative number; we encourage you to pick the cheaper option.

Competitor pricing reflects publicly listed rates as of May 14, 2026. We re-verify quarterly. If you spot an error, email us.

Lowest in industry · $29/mo

Save $1,440 per year on brand-name Foundayo™

Start your $29/mo Imbue Health membership and ship FDA-approved Foundayo™ from LillyDirect at manufacturer cash-pay pricing. No contracts.